HCID 44477405, compound → HCID 44476428, compound
Reaction equation
[CH:1]1([N:5]2[CH2:10][CH2:9][N:8]([C:11]([N:13]3[CH2:16][CH:15]([OH:17])[CH2:14]3)=[O:12])[CH2:7][CH2:6]2)[CH2:4][CH2:3][CH2:2]1.Cl[C:19]1[CH:20]=[CH:21][C:22]([C:25]([NH:27][CH3:28])=[O:26])=[N:23][CH:24]=1>CN(C=O)C>[CH:1]1([N:5]2[CH2:10][CH2:9][N:8]([C:11]([N:13]3[CH2:14][CH:15]([O:17][C:19]4[CH:20]=[CH:21][C:22]([C:25]([NH:27][CH3:28])=[O:26])=[N:23][CH:24]=4)[CH2:16]3)=[O:12])[CH2:7][CH2:6]2)[CH2:4][CH2:3][CH2:2]1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
In a similar fashion (Route 20, GP I; except using DMF instead of DMSO as solvent), 1-[(4-cyclobutylpiperazin-1-yl)carbonyl]azetidin-3-ol (150 mg, 0.63 mmol) and 5-chloro-N-methylpyridine-2-carboxamide (214 mg, 1.26 mmol) gave the title compound (156 mg, 0.42 mmol, 66%) as white solid after purification by FCC [SiO2 eluting with DCM/MeOH/NH3 98:2:0.5].
Sources & evidence
- ORD record
- ord-8f751e7f34d54416ac15752443b3346c
- Source dataset
- uspto-grants-2014_04
- Patent number
- US08691804B2
Reaction notes
Loading…